We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$17.8B
AUM Growth
+$1.56B
(+9.6%)
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
7.26%
Top 10 Holdings %
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$218M |
| 2 |
Super Micro Computer
SMCI
|
+$199M |
| 3 |
Apple
AAPL
|
+$185M |
| 4 |
Amazon
AMZN
|
+$174M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.3B |
| 2 |
Merck
MRK
|
+$203M |
| 3 |
Workday
WDAY
|
+$178M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$176M |
| 5 |
CRH
CRH
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Industrials | 7.93% |
| 3 | Consumer Discretionary | 7.91% |
| 4 | Financials | 7.65% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
876
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.36M | 0.01% |
+98,624
| New | +$1.44M |
|
877
Gentherm
THRM
$1.3B
| $1.36M | 0.01% |
27,560
+14,549
| +112% | +$752K |
|
878
PUT
iShares MSCI Australia ETF
EWA
$1.44B
| $1.36M | 0.01% |
+49,700
| New | +$1.21M |
|
879
Anterix
ATEX
$2.04B
| $1.36M | 0.01% |
+34,299
| New | +$1.11M |
|
880
LGI Homes
LGIH
$1.42B
| $1.36M | 0.01% |
15,156
-2,508
| -14% | -$242K |
|
881
Fox Class B
FOX
$22B
| $1.35M | 0.01% |
+42,346
| New | +$1.28M |
|
882
Elbit Systems
ESLT
$39.7B
| $1.35M | 0.01% |
7,660
+6,708
| +705% | +$1.31M |
|
883
Under Armour Class C
UA
$2.84B
| $1.35M | 0.01% |
206,976
+782
| +0.4% | +$5.18K |
|
884
Diageo
DEO
$48.9B
| $1.35M | 0.01% |
10,705
+9,322
| +674% | +$1.28M |
|
|
OXLC
885
Oxford Lane Capital
OXLC
$898M
| $1.35M | 0.01% |
49,731
-41,549
| -46% | -$1.09M |
|
|
UWC
886
PUT
DELISTED
PROSHARES TR ULTRA RUSSELL3000
UWC
| $1.34M | 0.01% |
+18,100
| New | +$1.34M |
|
|
NTST
887
NETSTREIT Corp
NTST
$2.05B
| $1.33M | 0.01% |
+82,825
| New | +$1.42M |
|
888
Xenon Pharmaceuticals
XENE
$6.18B
| $1.33M | 0.01% |
34,192
+1,584
| +5% | +$63.3K |
|
889
Mueller Water Products
MWA
$4.15B
| $1.33M | 0.01% |
+74,283
| New | +$1.28M |
|
890
Capitol Federal Financial
CFFN
$1.14B
| $1.33M | 0.01% |
242,188
+202,295
| +507% | +$1.05M |
|
891
Hanmi Financial
HAFC
$966M
| $1.33M | 0.01% |
79,341
-37,479
| -32% | -$584K |
|
892
Janus International
JBI
$768M
| $1.32M | 0.01% |
+104,783
| New | +$1.46M |
|
893
LXP Industrial Trust
LXP
$3.57B
| $1.32M | 0.01% |
28,992
+26,201
| +939% | +$1.15M |
|
894
Brookfield Renewable
BEP
$10.1B
| $1.31M | 0.01% |
+52,984
| New | +$1.32M |
|
|
895
CALL
Merck
MRK
$318B
| $1.31M | 0.01% |
+10,600
| New | +$1.37M |
|
896
American States Water
AWR
$3.33B
| $1.3M | 0.01% |
+17,991
| New | +$1.3M |
|
897
Theravance Biopharma
TBPH
$875M
| $1.3M | 0.01% |
153,424
+22,035
| +17% | +$199K |
|
|
SAGE
898
DELISTED
Sage Therapeutics
SAGE
| $1.29M | 0.01% |
+119,332
| New | +$1.53M |
|
899
Dorchester Minerals
DMLP
$1.23B
| $1.29M | 0.01% |
41,873
+20,119
| +92% | +$655K |
|
900
CALL
Nike
NKE
$61.9B
| $1.29M | 0.01% |
+17,100
| New | +$1.59M |
|
Similar funds
HRT Financial's Q2 2024 Portfolio in Review
As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.
- HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
- HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
- HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
- HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
- HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
- HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
- HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.
Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.